Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
TruBridge Q4 2025 Earnings Call - Strategic review, modest revenue growth and 200 bps EBITDA lift amid pipeline rebound
TruBridge closed 2025 with steady top-line, cleaner books, and a clear operational script: modest revenue growth and roughly 200 basis points of Adjusted EBITDA margin improvement targeted for 2026. M...
- Filed 10-K after an audit extension, citing out-of-period, non-cash adjustments tied to revenue recognition, capitalized software costs, and non-routine items; management stresses these were non-cash and do not materially change 2025 results.
- Company has initiated a formal strategic review to maximize shareholder value; no timeline provided and management will not issue formal guidance while the review is ongoing.
- Outlook: management expects modest revenue growth in 2026 and approximately 200 basis points of Adjusted EBITDA margin expansion, but did not provide numeric guidance due to the strategic review.
- +12 more takeaways
Jones Soda Co. Q4 and Full Year 2025 Earnings Call - Record Q4 Fueled by Fallout Licensing, Margin Gains, but HD9 Regulatory Drag
Jones Soda closed 2025 with a historic Q4, driven largely by Fallout-licensed product sales into club and DTC channels. Operational fixes and tighter cost controls lifted adjusted gross margins to 32%...
- Full year 2025 revenue was $25.3 million, up 42% from $17.8 million in 2024.
- Fourth quarter 2025 revenue was a company record $11.7 million, a 450% year-over-year increase driven primarily by Fallout-licensed product sales into club and DTC channels.
- Adjusted gross margin improved to 32% for both full year and Q4 2025, helped by lower trade spend and logistics improvements.
- +15 more takeaways
XBP Global Q4 2025 Earnings Call - AI-led margin gains clash with a revenue air pocket after Exela BPA integration
XBP Global spent 2025 stitching together the July acquisition of Exela Technologies BPA and repositioning itself as an AI-led provider of mission-critical workflows. The combined, pro forma picture sh...
- XBP completed the Exela Technologies BPA acquisition in late July 2025 and is operating as a single unified platform, XBP Global.
- Pro forma full year 2025 revenue was $879.6 million, down 13.6% year-over-year, driven by project completions and customer exits tied to BPA restructuring.
- Pro forma gross margin improved to 21.9% for the year, up 30 basis points, helped by a favorable mix toward higher-margin technology services and increased automation.
- +15 more takeaways
Nuvve Q4 2025 and FY 2025 Earnings Call - Pivot to stationary batteries and Omnia partnership with 150 MW announced projects
Nuvve spent 2025 repositioning from vehicle-to-grid deployments toward stationary battery ownership and management, leaning on a newly announced partnership with Omnia Global and a separate push in Ja...
- Nuvve is pivoting from vehicle-to-grid (V2G) focus to stationary battery deployments, a transition begun more than a year ago and now front-and-center in strategy.
- The company announced a partnership with Omnia Global, tapping into Omnia’s stated 1 GW-plus European battery pipeline, and Nuvve disclosed three projects totaling 150 MW: 50 MW (75 MWh) in Sweden, 40 MW (80 MWh) in Austria, and 60 MW (120 MWh) in Romania.
- Management says Nuvve intends to own these European battery assets, aiming to capture higher, recurring grid service revenues rather than just charger sales or management fees.
- +13 more takeaways
Workhorse Q4 and Full Year 2025 Earnings Call - Merger with Motiv sets path to profitability with 2,500-unit breakeven and $20M synergies
Workhorse closed its merger with Motiv in December 2025 and used the combination to reset strategy, manufacturing, and cost structure. Management says the merged company already has scale in the field...
- Merger closed December 15, 2025, with Motiv accounted for on a reverse merger basis; Q4 and FY results reflect Motiv standalone through Dec 15 and combined thereafter.
- Management frames the merger as transformational, combining product portfolios across Class 4, 5, and 6 and more than $860 million of prior invested capital.
- Installed base and validation: more than 1,100 vehicles operating with over 20 million cumulative miles, serving 10 of North America’s largest medium-duty fleets, with documented repeat purchase behavior.
- +11 more takeaways
Banzai Q4 2025 Earnings Call - Acquisition-Fueled Revenue Surge, ConnectAndSell to More Than Double Run Rate
Banzai closed 2025 with a sprint. Revenue jumped 169% for the year to $12.2 million, Q4 revenue rose 116% to $2.8 million, and gross margin expanded to roughly 82% as video and AI assets like Vidello ...
- Revenue grew 116% year-over-year in Q4 2025 to $2.8 million, and full year 2025 revenue rose 169% to $12.2 million, driven largely by acquisitions Vidello and OpenReel.
- Gross profit expanded 221% year-over-year to $10.0 million for 2025, lifting gross margin to approximately 82% from 68.6% in 2024.
- Operating expenses rose sharply to $28.4 million in 2025, primarily due to the addition of acquired businesses, contributing to a full year net loss of $22.5 million (improved from $31.5 million).
- +12 more takeaways
Barfresh Food Group Q4 2025 Earnings Call - Arps Dairy Buy Gives Control of Manufacturing, Promises Path to $200M Revenue Capacity
Barfresh closed 2025 with record revenue but squeezed margins, after a year defined by a strategic acquisition and a financing deal that retools the company's operating model. The October acquisition ...
- Record revenue for 2025: $14.2 million, up 33% year over year; Q4 2025 revenue was $5.4 million, a 94% y/y increase.
- Acquisition of Arps Dairy (Oct 2025) added a 15,000 sq ft processing plant and a 44,000 sq ft manufacturing facility in Defiance, Ohio, shifting production in-house.
- Post-acquisition production mix now roughly 90% in-house, reducing dependence on third-party co-manufacturers that previously constrained growth.
- +12 more takeaways
Edible Garden AG Q4 2025 Earnings Call - RTD push aims to pivot company to higher-margin CPG
Edible Garden spent 2025 reshaping itself from a controlled-environment produce supplier into a broader CPG player, leaning hard into ready-to-drink protein and nutraceuticals. Management reported dis...
- Distribution and retail wins: management expanded national distribution to nearly 6,000 store locations, adding more than 700 incremental retail placements in Q4, including Kroger, Weis Markets, Safeway, The Fresh Market, Busch’s, Wakefern and others.
- Q4 revenue and YoY: revenue for the three months ended December 31, 2025 was approximately $4.1 million, up from $3.9 million in Q4 2024.
- Q4 cost and gross results: cost of goods sold in Q4 was about $5.3 million versus $3.8 million a year earlier, producing a Q4 gross loss of approximately $1.2 million, compared with flat gross profit in Q4 2024.
- +12 more takeaways
Rekor Systems, Inc. FY2025 Earnings Call - Margin Inflection as Company Repositions Toward Recurring Software and Onshored Engineering
Rekor says FY2025 was a turning point, delivering modest top-line growth while cutting costs and shifting the business mix toward higher-margin software and data subscriptions. Revenue rose to $48.5 m...
- Revenue for the year ended December 31, 2025 was $48.5 million, up 5% from $46.0 million in 2024.
- Recurring revenue was $23.9 million in 2025, up 6% year-over-year, roughly a 50/50 split between recurring and equipment revenue.
- Remaining performance obligations rose to $25.9 million as of December 31, 2025, an increase of nearly 80% from a year earlier, cited as pipeline momentum into 2026.
- +13 more takeaways
Co-Diagnostics Inc. Q4 2025 Earnings Call - India TB commercialization becomes the focus as losses mount
Co-Diagnostics used the call to signal a clear pivot: India and TB diagnostics are now the most immediate commercial levers. Management highlighted CoSara’s manufacturing license, 15 locally cleared t...
- Nasdaq relisting completed, management emphasizing forward execution after the temporary listing disruption.
- Company organized growth around four pillars: clinical regulatory progress, CoSara/India strategy and alternatives, CoMira expansion in Saudi and MENA, and AI-driven platform capabilities.
- CoSara joint venture in India received CDSCO license to manufacture the PCR Pro instrument, and CoSara now services hundreds of labs with 15 PCR tests cleared locally.
- +12 more takeaways